APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cisatracurium Besylate Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Cisatracurium Besylate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026197 pages

Choose your research edition.

Industry ResearchCisatracurium Besylate Injection Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Cisatracurium Besylate Injection Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Cisatracurium Besylate Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cisatracurium Besylate Injection Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Cisatracurium Besylate Injection Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Cisatracurium Besylate Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Cisatracurium Besylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Cisatracurium Besylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cisatracurium Besylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Cisatracurium Besylate Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cisatracurium Besylate Injection include Meitheal Pharmaceuticals, AbbVie, Fresenius Kabi, Pfizer, Jiangsu Singchn, Sandoz, Shanghai Sino Biopharma, Shanghai Hengrui Pharmaceutical and Teva, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Cisatracurium Besylate Injection market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Cisatracurium Besylate Injection and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Cisatracurium Besylate Injection sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Cisatracurium Besylate Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

Cisatracurium Besylate Injection Segment by Company

Meitheal Pharmaceuticals

AbbVie

Fresenius Kabi

Pfizer

Jiangsu Singchn

Sandoz

Shanghai Sino Biopharma

Shanghai Hengrui Pharmaceutical

Teva

Xianju Pharma

Cisatracurium Besylate Injection Segment by Type

2 mg/mL

5 mg/mL

10 mg/mL

Cisatracurium Besylate Injection Segment by Application

Clinics

Hospital

Recovery Center

Cisatracurium Besylate Injection Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cisatracurium Besylate Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cisatracurium Besylate Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cisatracurium Besylate Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Cisatracurium Besylate Injection market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cisatracurium Besylate Injection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Cisatracurium Besylate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Cisatracurium Besylate Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Cisatracurium Besylate Injection Industry Trends Table 2. Cisatracurium Besylate Injection Industry Drivers Table 3. Cisatracurium Besylate Injection Industry Opportunities and Challenges Table 4. Cisatracurium Besylate Injection Industry Restraints Table 5. Global Cisatracurium Besylate Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Cisatracurium Besylate Injection Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Cisatracurium Besylate Injection Sales by Manufacturers (W Units) & (2021-2026) Table 8. Global Cisatracurium Besylate Injection Sales Market Share by Manufacturers Table 9. Global Cisatracurium Besylate Injection Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Cisatracurium Besylate Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Cisatracurium Besylate Injection Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Cisatracurium Besylate Injection Manufacturers, Product Type & Application Table 13. Global Cisatracurium Besylate Injection Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Cisatracurium Besylate Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 2 mg/mL Table 17. Major Manufacturers of 5 mg/mL Table 18. Major Manufacturers of 10 mg/mL Table 19. Global Cisatracurium Besylate Injection Sales by Type 2021 VS 2025 VS 2032 (W Units) Table 20. Global Cisatracurium Besylate Injection Sales by Type (2021-2026) & (W Units) Table 21. Global Cisatracurium Besylate Injection Sales by Type (2027-2032) & (W Units) Table 22. Global Cisatracurium Besylate Injection Sales Market Share by Type (2021-2026) Table 23. Global Cisatracurium Besylate Injection Sales Market Share by Type (2027-2032) Table 24. Global Cisatracurium Besylate Injection Revenue by Type 2021 VS 2025 VS 2032 (W Units) Table 25. Global Cisatracurium Besylate Injection Revenue by Type (2021-2026) & (W Units) Table 26. Global Cisatracurium Besylate Injection Revenue by Type (2027-2032) & (W Units) Table 27. Global Cisatracurium Besylate Injection Revenue Market Share by Type (2021-2026) Table 28. Global Cisatracurium Besylate Injection Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Clinics Table 30. Major Manufacturers of Hospital Table 31. Major Manufacturers of Recovery Center Table 32. Global Cisatracurium Besylate Injection Sales by Application 2021 VS 2025 VS 2032 (W Units) Table 33. Global Cisatracurium Besylate Injection Sales by Application (2021-2026) & (W Units) Table 34. Global Cisatracurium Besylate Injection Sales by Application (2027-2032) & (W Units) Table 35. Global Cisatracurium Besylate Injection Sales Market Share by Application (2021-2026) Table 36. Global Cisatracurium Besylate Injection Sales Market Share by Application (2027-2032) Table 37. Global Cisatracurium Besylate Injection Revenue by Application 2021 VS 2025 VS 2032 (W Units) Table 38. Global Cisatracurium Besylate Injection Revenue by Application (2021-2026) & (W Units) Table 39. Global Cisatracurium Besylate Injection Revenue by Application (2027-2032) & (W Units) Table 40. Global Cisatracurium Besylate Injection Revenue Market Share by Application (2021-2026) Table 41. Global Cisatracurium Besylate Injection Revenue Market Share by Application (2027-2032) Table 42. Global Cisatracurium Besylate Injection Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 43. Global Cisatracurium Besylate Injection Sales by Region (2021-2026) & (W Units) Table 44. Global Cisatracurium Besylate Injection Sales Market Share by Region (2021-2026) Table 45. Global Cisatracurium Besylate Injection Sales Forecasted by Region (2027-2032) & (W Units) Table 46. Global Cisatracurium Besylate Injection Sales Forecasted Market Share by Region (2027-2032) Table 47. North America Cisatracurium Besylate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 48. North America Cisatracurium Besylate Injection Sales by Country (2021-2026) & (W Units) Table 49. North America Cisatracurium Besylate Injection Sales by Country (2027-2032) & (W Units) Table 50. Europe Cisatracurium Besylate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 51. Europe Cisatracurium Besylate Injection Sales by Country (2021-2026) & (W Units) Table 52. Europe Cisatracurium Besylate Injection Sales by Country (2027-2032) & (W Units) Table 53. Asia Pacific Cisatracurium Besylate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 54. Asia Pacific Cisatracurium Besylate Injection Sales by Country (2021-2026) & (W Units) Table 55. Asia Pacific Cisatracurium Besylate Injection Sales by Country (2027-2032) & (W Units) Table 56. South America, Middle East and Africa Cisatracurium Besylate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (W Units) Table 57. South America, Middle East and Africa Cisatracurium Besylate Injection Sales by Country (2021-2026) & (W Units) Table 58. South America, Middle East and Africa Cisatracurium Besylate Injection Sales by Country (2027-2032) & (W Units) Table 59. Global Cisatracurium Besylate Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Cisatracurium Besylate Injection Revenue by Region (2021-2026) & (US$ Million) Table 61. Global Cisatracurium Besylate Injection Revenue by Region (2027-2032) & (US$ Million) Table 62. Global Cisatracurium Besylate Injection Revenue Market Share by Region (2021-2026) Table 63. Global Cisatracurium Besylate Injection Revenue Market Share by Region (2027-2032) Table 64. Meitheal Pharmaceuticals Company Information Table 65. Meitheal Pharmaceuticals Business Overview Table 66. Meitheal Pharmaceuticals Cisatracurium Besylate Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Meitheal Pharmaceuticals Cisatracurium Besylate Injection Product Portfolio Table 68. Meitheal Pharmaceuticals Recent Development Table 69. AbbVie Company Information Table 70. AbbVie Business Overview Table 71. AbbVie Cisatracurium Besylate Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. AbbVie Cisatracurium Besylate Injection Product Portfolio Table 73. AbbVie Recent Development Table 74. Fresenius Kabi Company Information Table 75. Fresenius Kabi Business Overview Table 76. Fresenius Kabi Cisatracurium Besylate Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Fresenius Kabi Cisatracurium Besylate Injection Product Portfolio Table 78. Fresenius Kabi Recent Development Table 79. Pfizer Company Information Table 80. Pfizer Business Overview Table 81. Pfizer Cisatracurium Besylate Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Pfizer Cisatracurium Besylate Injection Product Portfolio Table 83. Pfizer Recent Development Table 84. Jiangsu Singchn Company Information Table 85. Jiangsu Singchn Business Overview Table 86. Jiangsu Singchn Cisatracurium Besylate Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. Jiangsu Singchn Cisatracurium Besylate Injection Product Portfolio Table 88. Jiangsu Singchn Recent Development Table 89. Sandoz Company Information Table 90. Sandoz Business Overview Table 91. Sandoz Cisatracurium Besylate Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Sandoz Cisatracurium Besylate Injection Product Portfolio Table 93. Sandoz Recent Development Table 94. Shanghai Sino Biopharma Company Information Table 95. Shanghai Sino Biopharma Business Overview Table 96. Shanghai Sino Biopharma Cisatracurium Besylate Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 97. Shanghai Sino Biopharma Cisatracurium Besylate Injection Product Portfolio Table 98. Shanghai Sino Biopharma Recent Development Table 99. Shanghai Hengrui Pharmaceutical Company Information Table 100. Shanghai Hengrui Pharmaceutical Business Overview Table 101. Shanghai Hengrui Pharmaceutical Cisatracurium Besylate Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 102. Shanghai Hengrui Pharmaceutical Cisatracurium Besylate Injection Product Portfolio Table 103. Shanghai Hengrui Pharmaceutical Recent Development Table 104. Teva Company Information Table 105. Teva Business Overview Table 106. Teva Cisatracurium Besylate Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 107. Teva Cisatracurium Besylate Injection Product Portfolio Table 108. Teva Recent Development Table 109. Xianju Pharma Company Information Table 110. Xianju Pharma Business Overview Table 111. Xianju Pharma Cisatracurium Besylate Injection Sales (W Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 112. Xianju Pharma Cisatracurium Besylate Injection Product Portfolio Table 113. Xianju Pharma Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Cisatracurium Besylate Injection Distributors List Table 117. Cisatracurium Besylate Injection Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Cisatracurium Besylate Injection Product Image Figure 2. Global Cisatracurium Besylate Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cisatracurium Besylate Injection Market Size (2021-2032) & (US$ Million) Figure 4. Global Cisatracurium Besylate Injection Sales (2021-2032) & (W Units) Figure 5. Global Cisatracurium Besylate Injection Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Cisatracurium Besylate Injection Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 2 mg/mL Image Figure 9. 5 mg/mL Image Figure 10. 10 mg/mL Image Figure 11. Global Cisatracurium Besylate Injection Sales by Type (2021 VS 2025 VS 2032) & (W Units) Figure 12. Global Cisatracurium Besylate Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Cisatracurium Besylate Injection Sales Market Share by Type (2021-2032) Figure 14. Global Cisatracurium Besylate Injection Revenue by Type (2021 VS 2025 VS 2032) & (W Units) Figure 15. Global Cisatracurium Besylate Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Cisatracurium Besylate Injection Revenue Market Share by Type (2021-2032) Figure 17. Clinics Image Figure 18. Hospital Image Figure 19. Recovery Center Image Figure 20. Global Cisatracurium Besylate Injection Sales by Application (2021 VS 2025 VS 2032) & (W Units) Figure 21. Global Cisatracurium Besylate Injection Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global Cisatracurium Besylate Injection Sales Market Share by Application (2021-2032) Figure 23. Global Cisatracurium Besylate Injection Revenue by Application (2021 VS 2025 VS 2032) & (W Units) Figure 24. Global Cisatracurium Besylate Injection Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global Cisatracurium Besylate Injection Revenue Market Share by Application (2021-2032) Figure 26. North America Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 27. North America Cisatracurium Besylate Injection Sales Market Share by Country (2021-2032) Figure 28. U.S. Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 29. Canada Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 30. Mexico Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 31. Europe Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 32. Europe Cisatracurium Besylate Injection Sales Market Share by Country (2021-2032) Figure 33. Germany Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 34. France Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 35. U.K. Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 36. Italy Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 37. Netherlands Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 38. Asia Pacific Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 39. Asia Pacific Cisatracurium Besylate Injection Sales Market Share by Country (2021-2032) Figure 40. China Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 41. Japan Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 42. South Korea Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 43. Southeast Asia Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 44. India Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 45. Australia Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 46. South America, Middle East and Africa Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 47. South America, Middle East and Africa Cisatracurium Besylate Injection Sales Market Share by Country (2021-2032) Figure 48. Brazil Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 49. South Africa Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 50. Saudi Arabia Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 51. Turkey Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 52. Argentina Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 53. UAE Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 54. Egypt Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 55. Chile Cisatracurium Besylate Injection Sales and Growth Rate (2021-2032) & (W Units) Figure 56. Global Cisatracurium Besylate Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global Cisatracurium Besylate Injection Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America Cisatracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Figure 59. North America Cisatracurium Besylate Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe Cisatracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Figure 61. Europe Cisatracurium Besylate Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific Cisatracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific Cisatracurium Besylate Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa Cisatracurium Besylate Injection Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa Cisatracurium Besylate Injection Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Cisatracurium Besylate Injection Value Chain Figure 67. Manufacturing Cost Structure Figure 68. Cisatracurium Besylate Injection Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • 2 mg/mL
  • 5 mg/mL
  • 10 mg/mL
Applications
  • Clinics
  • Hospital
  • Recovery Center
Companies covered
  • Meitheal Pharmaceuticals
  • AbbVie
  • Fresenius Kabi
  • Pfizer
  • Jiangsu Singchn
  • Sandoz
  • Shanghai Sino Biopharma
  • Shanghai Hengrui Pharmaceutical
  • Teva
  • Xianju Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Cisatracurium Besylate Injection Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Cisatracurium Besylate Injection Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Cisatracurium Besylate Injection Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Cisatracurium Besylate Injection Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Cisatracurium Besylate Injection Market Dynamics
  1. 2.1 Cisatracurium Besylate Injection Industry Trends
  2. 2.2 Cisatracurium Besylate Injection Industry Drivers
  3. 2.3 Cisatracurium Besylate Injection Industry Opportunities and Challenges
  4. 2.4 Cisatracurium Besylate Injection Industry Restraints
3 Cisatracurium Besylate Injection Market by Manufacturers
  1. 3.1 Global Cisatracurium Besylate Injection Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Cisatracurium Besylate Injection Sales by Manufacturers (2021-2026)
  3. 3.3 Global Cisatracurium Besylate Injection Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Cisatracurium Besylate Injection Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cisatracurium Besylate Injection Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Cisatracurium Besylate Injection Manufacturers, Product Type & Application
  7. 3.7 Global Cisatracurium Besylate Injection Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cisatracurium Besylate Injection Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cisatracurium Besylate Injection Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cisatracurium Besylate Injection Tier 1, Tier 2, and Tier 3
4 Cisatracurium Besylate Injection Market by Type
  1. 4.1 Cisatracurium Besylate Injection Type Introduction
  2. 4.1.1 2 mg/mL
  3. 4.1.2 5 mg/mL
  4. 4.1.3 10 mg/mL
  5. 4.2 Global Cisatracurium Besylate Injection Sales by Type
  6. 4.2.1 Global Cisatracurium Besylate Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Cisatracurium Besylate Injection Sales by Type (2021-2032)
  8. 4.2.3 Global Cisatracurium Besylate Injection Sales Market Share by Type (2021-2032)
  9. 4.3 Global Cisatracurium Besylate Injection Revenue by Type
  10. 4.3.1 Global Cisatracurium Besylate Injection Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Cisatracurium Besylate Injection Revenue by Type (2021-2032)
  12. 4.3.3 Global Cisatracurium Besylate Injection Revenue Market Share by Type (2021-2032)
5 Cisatracurium Besylate Injection Market by Application
  1. 5.1 Cisatracurium Besylate Injection Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospital
  4. 5.1.3 Recovery Center
  5. 5.2 Global Cisatracurium Besylate Injection Sales by Application
  6. 5.2.1 Global Cisatracurium Besylate Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Cisatracurium Besylate Injection Sales by Application (2021-2032)
  8. 5.2.3 Global Cisatracurium Besylate Injection Sales Market Share by Application (2021-2032)
  9. 5.3 Global Cisatracurium Besylate Injection Revenue by Application
  10. 5.3.1 Global Cisatracurium Besylate Injection Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Cisatracurium Besylate Injection Revenue by Application (2021-2032)
  12. 5.3.3 Global Cisatracurium Besylate Injection Revenue Market Share by Application (2021-2032)
6 Global Cisatracurium Besylate Injection Sales by Region
  1. 6.1 Global Cisatracurium Besylate Injection Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Cisatracurium Besylate Injection Sales by Region (2021-2032)
  3. 6.2.1 Global Cisatracurium Besylate Injection Sales by Region (2021-2026)
  4. 6.2.2 Global Cisatracurium Besylate Injection Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Cisatracurium Besylate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Cisatracurium Besylate Injection Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Cisatracurium Besylate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Cisatracurium Besylate Injection Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Cisatracurium Besylate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Cisatracurium Besylate Injection Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Cisatracurium Besylate Injection Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Cisatracurium Besylate Injection Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Cisatracurium Besylate Injection Revenue by Region
  1. 7.1 Global Cisatracurium Besylate Injection Revenue by Region
  2. 7.1.1 Global Cisatracurium Besylate Injection Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Cisatracurium Besylate Injection Revenue by Region (2021-2026)
  4. 7.1.3 Global Cisatracurium Besylate Injection Revenue by Region (2027-2032)
  5. 7.1.4 Global Cisatracurium Besylate Injection Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Cisatracurium Besylate Injection Revenue (2021-2032)
  8. 7.2.2 North America Cisatracurium Besylate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Cisatracurium Besylate Injection Revenue (2021-2032)
  11. 7.3.2 Europe Cisatracurium Besylate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Cisatracurium Besylate Injection Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Cisatracurium Besylate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Cisatracurium Besylate Injection Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Cisatracurium Besylate Injection Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Meitheal Pharmaceuticals
  2. 8.1.1 Meitheal Pharmaceuticals Company Information
  3. 8.1.2 Meitheal Pharmaceuticals Business Overview
  4. 8.1.3 Meitheal Pharmaceuticals Cisatracurium Besylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Meitheal Pharmaceuticals Cisatracurium Besylate Injection Product Portfolio
  6. 8.1.5 Meitheal Pharmaceuticals Recent Developments
  7. 8.2 AbbVie
  8. 8.2.1 AbbVie Company Information
  9. 8.2.2 AbbVie Business Overview
  10. 8.2.3 AbbVie Cisatracurium Besylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 AbbVie Cisatracurium Besylate Injection Product Portfolio
  12. 8.2.5 AbbVie Recent Developments
  13. 8.3 Fresenius Kabi
  14. 8.3.1 Fresenius Kabi Company Information
  15. 8.3.2 Fresenius Kabi Business Overview
  16. 8.3.3 Fresenius Kabi Cisatracurium Besylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Fresenius Kabi Cisatracurium Besylate Injection Product Portfolio
  18. 8.3.5 Fresenius Kabi Recent Developments
  19. 8.4 Pfizer
  20. 8.4.1 Pfizer Company Information
  21. 8.4.2 Pfizer Business Overview
  22. 8.4.3 Pfizer Cisatracurium Besylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Cisatracurium Besylate Injection Product Portfolio
  24. 8.4.5 Pfizer Recent Developments
  25. 8.5 Jiangsu Singchn
  26. 8.5.1 Jiangsu Singchn Company Information
  27. 8.5.2 Jiangsu Singchn Business Overview
  28. 8.5.3 Jiangsu Singchn Cisatracurium Besylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Jiangsu Singchn Cisatracurium Besylate Injection Product Portfolio
  30. 8.5.5 Jiangsu Singchn Recent Developments
  31. 8.6 Sandoz
  32. 8.6.1 Sandoz Company Information
  33. 8.6.2 Sandoz Business Overview
  34. 8.6.3 Sandoz Cisatracurium Besylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sandoz Cisatracurium Besylate Injection Product Portfolio
  36. 8.6.5 Sandoz Recent Developments
  37. 8.7 Shanghai Sino Biopharma
  38. 8.7.1 Shanghai Sino Biopharma Company Information
  39. 8.7.2 Shanghai Sino Biopharma Business Overview
  40. 8.7.3 Shanghai Sino Biopharma Cisatracurium Besylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Shanghai Sino Biopharma Cisatracurium Besylate Injection Product Portfolio
  42. 8.7.5 Shanghai Sino Biopharma Recent Developments
  43. 8.8 Shanghai Hengrui Pharmaceutical
  44. 8.8.1 Shanghai Hengrui Pharmaceutical Company Information
  45. 8.8.2 Shanghai Hengrui Pharmaceutical Business Overview
  46. 8.8.3 Shanghai Hengrui Pharmaceutical Cisatracurium Besylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Shanghai Hengrui Pharmaceutical Cisatracurium Besylate Injection Product Portfolio
  48. 8.8.5 Shanghai Hengrui Pharmaceutical Recent Developments
  49. 8.9 Teva
  50. 8.9.1 Teva Company Information
  51. 8.9.2 Teva Business Overview
  52. 8.9.3 Teva Cisatracurium Besylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Teva Cisatracurium Besylate Injection Product Portfolio
  54. 8.9.5 Teva Recent Developments
  55. 8.10 Xianju Pharma
  56. 8.10.1 Xianju Pharma Company Information
  57. 8.10.2 Xianju Pharma Business Overview
  58. 8.10.3 Xianju Pharma Cisatracurium Besylate Injection Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Xianju Pharma Cisatracurium Besylate Injection Product Portfolio
  60. 8.10.5 Xianju Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Cisatracurium Besylate Injection Value Chain Analysis
  2. 9.1.1 Cisatracurium Besylate Injection Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Cisatracurium Besylate Injection Production Mode & Process
  6. 9.2 Cisatracurium Besylate Injection Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Cisatracurium Besylate Injection Distributors
  9. 9.2.3 Cisatracurium Besylate Injection Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst